Cybersecurity is taking center stage again. This time for a good reason. Back on Jan. 5, we noted: In 2023, experts warn we could see a sharp rise in attacks. “According to an analysis by Cybersecurity Venture, the global annual…
Markets
Chinese stocks are on the move, as hoped. In fact, as we noted on Jan. 10: “It’s been a rough couple of years for China. The pandemic coupled with Beijing’s zero-COVID policy slammed its economy. That was on top of…
For quite some time, space tourism was the most exciting topic on the Street. Then, it became more laughable than Looney Tune’s space traveling, Daffy Duck in the 24 ½ Century. It flopped… But if all goes according to plan,…
Fear is one of the greatest investment tools on the market. In fact, some of the world’s most well-known investors used it to get filthy rich, including Sir John Templeton, Baron Rothschild, and Warren Buffett. Sir John Templeton wasn’t your…
Cryptocurrencies are seeing some green early in the year after being in free fall for the better part of 2022. The sector is showing signs of bottoming out as oversold conditions make most of the digital assets highly attractive on…
Investors may want to keep an eye on Mobileye (MBLY). Especially on recent weakness. For one, as noted by CNBC, “Founded in 1999, Mobileye has partnered with Audi, BMW, Volkswagen, GM, and Ford to develop advanced driving and safety features…
We just don’t learn. The world is well aware of cyber threats. Yet, we’re still not doing enough. And whatever we are doing is being met with giggles from cyber criminals. Cities, hospitals, schools, government agencies are all vulnerable. Even…
As always, be sure to do your own due diligence before investing in any stock to make sure it’s right for your financial situation and that it is consistent with your acceptable level of risk. Stocks Under $10: Standard Lithium…
Some of the market’s best opportunities can still be found in dividend stocks. Especially in this crazed environment. While we’re finally leaving 2022 behind, the first half of the new year could be much of the same, which is why…
Pfizer (PFE) is breaking out, as hoped. As we noted on December 8, “The stock could race higher on two key catalysts. One, Pfizer and BioNTech just received US FDA Emergency Use Authorization for its BA.4 – BA.5 COVID vaccine…